Journal of IiME Volume 2 Issue 1 www.investinme.org Possible application of visible and near-infrared spectral patterns in serum to provide emerging clue to biomarkers for chronic fatigue syndrome (continued) chronic fatigue syndrome. Clin Infect Dis, 18 Suppl 1:S6267. Maes, M., Mihaylova, I., De Ruyter, M. 2006. Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS. J Affect Disord, 90:141-147. Murray, I. 1993. Forage analysis by near infra-red spectroscopy. In: Davies, A., Baker, R. D., Grant, S. A. (Ed.) Sward Management Handbook, British Grassland Society, UK, pp. 285-312 Nijs, J., De Meirleir, K. 2005. Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome. In Vivo, 19:1013-1021. Parker, A.J., Wessely, S., Cleare, A.J. 2001. The neuroendocrinology of chronic fatigue syndrome and fibromyalgia. Psychol Med, 31:1331-1345. Patarca, R. 2001. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci, 933:185-200. Reyes, M., Nisenbaum, R., Hoaglin, D.C., Unger, E.R., Emmons, C., Randall, B., Stewart, J.A., Abbey, S., Jones, J.F., Gantz, N., Minden, S., Reeves, W.C. 2003. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med, 163:1530-1536. Reynolds, K.J., Vernon, S.D., Bouchery, E., Reeves, W.C. 2004. The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc, 2:4. Sakudo, A., Kuratsune, H., Kobayashi, T., Tajima, S., Watanabe, Y., Ikuta, K. 2006. Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples. Biochem Biophys Res Commun, 345:1513-1516. Stuart, B. 1997. Biological Applications of Infrared Spectroscopy John Wiley & Sons Ltd New York. Vernon, S.D., Reeves, W.C. 2005. Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis, 2:5. Vernon, S.D., Whistler, T., Aslakson, E., Rajeevan, M., Reeves, W.C. 2006. Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics, 7:211-218. Werbach, M.R. 2000. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev, 5:93-108. Whiteside, T.L., Friberg, D. 1998. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med, 105:27S-34S. Person With ME I have just read about your book (ME Book Project), what a good idea! I have had M E for nearly 4 years now and I can say that it has devastated my life, everyday just feels like walking against the wind. Where once I could participate, now I can only observe. I have become a very diluted form of who I once was. Well done for trying to highlight this illness. - Melanie ME Story ME patients are unfortunate with their doctors. While most other patient groups have a trusting relationship with the medical profession, far too often ME patients complain of neglect, abuse, misdiagnosis and stigma. Our patients have a visceral dislike of the psychiatric construct of ME, and for good reason. Besides the disadvantages of misdiagnosis, it forces them into a clinical environment where the validity of their opinions is routinely delegitimized, where their right to give informed consent is often not respected, and where in some cases they may be subjected to involuntary detention. These are fears which lurk in the minds of all ME patients. For Sophia Mirza they became a nightmare reality. - Horace Reid (on the story of Sophia Mirza) Invest in ME (Charity Nr. 1114035) Page 7/34
8 Publizr Home